LON:BIOG

The Biotech Growth Trust Interim Earnings Results & Report

The Biotech Growth Trust logo
GBX 1,354 +16.00 (+1.20%)
As of 12:28 PM Eastern

The Biotech Growth Trust reported Interim earnings on November 17, 2026. The company reported EPS of -GBX 2.10, while revenue was £100 thousand.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

The Biotech Growth Trust EPS Results

Actual EPS
-GBX 2.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

The Biotech Growth Trust Revenue Results

Actual Revenue
£100 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

The Biotech Growth Trust Interim Earnings FAQ

The Biotech Growth Trust (LON:BIOG) reported earnings of -GBX 2.10 per share for Interim. The report was announced on Tuesday, November 17, 2026.

The Biotech Growth Trust reported revenue of £100 thousand for Interim.

The Biotech Growth Trust Earnings Headlines

The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 October 2026
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
The Biotech Growth Trust PLC - Total Voting Rights
(BIOGW) Biotech Growth Trust Plc
See More The Biotech Growth Trust Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like The Biotech Growth Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your email.

About The Biotech Growth Trust

The Biotech Growth Trust (LON:BIOG) seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

View The Biotech Growth Trust Profile